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Cryptosporidium parvum is a common, opportunistic, diarrhoeal-causing, 
apicomplexan pathogen in humans, of which water is an important transmission 
vehicle. Recently, aquatic biofilms have been recognised as environmental reservoirs 
for the infective stage (oocysts) of Cryptosporidium, yet their fate after being trapped 
within biofilms is unknown. Previous cell-associated and cell-free studies have 
demonstrated, controversially, that Cryptosporidium may be able to multiply 
extracellularly, indicating that Cryptosporidium is not an obligate intracellular 
microorganism, and that the environment may play an important role in shaping its 
life cycle. Previously published data raise the question as to whether 
Cryptosporidium can survive and multiply within biofilms, resulting in an increase 
in numbers before release into water systems, leading to possible disease outbreaks.  
This study, therefore, aimed to investigate the ability of biofilms to support 
Cryptosporidium multiplication. This was achieved using a combination of 
quantitative polymerase chain reaction (qPCR), flow cytometry (immunolabeled 
with Cryptosporidium oocysts-specific antibody), confocal microscopy 
(immunolabeled with Cryptosporidium developmental stage-specific antibody) and 
scanning electron microscopy (SEM) techniques. To mimic a water distribution 
system, Pseudomonas aeruginosa biofilm flow cell systems were established and 
unexcysted C. parvum oocysts were constantly supplied over a 6-day period. Prior to 
analysis, the four analytical methods were designed and empirically optimised 
according to the nature of the experimental sample studied.  
Quantitative PCR results showed a significant increase (P<0.001) in 
Cryptosporidium as the biofilm matured, with the total number of C. parvum 
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multiplying 2-3 fold during this period. Flow cytometry analysis also revealed that 
the captured oocysts had undergone excystation in biofilms, confirming that the 
increase in Cryptosporidium number was due to Cryptosporidium multiplication. 
From this, various Cryptosporidium developmental stages (sporozoites, trophozoites, 
meronts, and merozoites) were also identified from the biofilm using confocal 
microscopy and SEM. A correlative study using both SEM and confocal imaging 
determined that the observed developmental stages were Cryptosporidium, rather 
than degenerate/accumulated oocysts or yeast contamination. Furthermore, SEM 
analysis also revealed that Cryptosporidium may form a parasitophorous vacuole 
independently, potentially allowing it to complete its life cycle extracellularly. In 
addition, certain stages of the Cryptosporidium life cycle (trophozoites, meronts, and 
some previously undescribed gamonts) in biofilms were identified, and shown to 
closely resemble stages reported in the gregarine life cycle, emphasising the 
possibility that Cryptosporidium has inherited the capability to multiply 
extracellularly from their gregarine ancestor.  
In conclusion, this study has successfully shown that biofilms can support 
Cryptosporidium multiplication in aquatic environments and thus, also demonstrated 
a role for biofilms in outbreaks and spreading of this disease. The generated results 
are novel, offering new insights into the role of biofilms in the C. parvum life cycle, 
providing additional information for water authorities, aiding in the control of 
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